The expansion project, which began in mid-2019, added a large amount of available solid-dose packaging capacity

Aphena Cookeville Tennessee

Aphena announces completion of $20m expansion of its Tennessee plant. (Credit: Aphena Pharma Solutions)

Aphena Pharma Solutions has announced the completion of its $20m expansion and renovation of its plant in Cookeville, Tennessee.

The expansion project, which began in mid-2019, added a large amount of available solid dose packaging capacity.

Aphena Pharma said the plant has now four additional high-speed bottling lines and two additional high-speed blister lines for solid-based products.

The additional space and capabilities have increased the company’s bottle and blister packaging capacity. The expansion makes Aphena a strong strategic growth partner for any generic or over-the-counter (OTC) pharmaceutical company, the firm said.

Aphena president and COO Eric Allen said: “The expansion added a new 500,000-square-foot facility that is purpose-built for FDA pharmaceutical packaging of solid dose and biologic products.

“In addition, the new facility has now been FDA inspected, and we have completed our first group of generic and brand product transfers with FDA approval.”

Aphena Pharma Solutions provides contract packaging and manufacturing services for the pharmaceutical, consumer health, biologics, and medical device industries.

The firm manages solid dosage, liquid, gel, cream, ointment, foam, suspension, and lotion-based products in two distinct US Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA)-registered facilities in the US.

Aphena sales senior director Paul Glintenkamp said: “We are very excited to be able to provide this level of capacity to continue to support the pharmaceutical generic and OTC industries.

“This new facility allows Aphena to continue its positive growth with much larger pharmaceutical partners, effectively making us one of the top five United States-based contract packaging companies in the pharmaceutical industry.”

In November 2020, the pharmaceuticals company commissioned a new facility in Tennessee, US to offer cold chain storage and large-scale biologics packaging and distribution services.